NIH-funded research Career grant

New test for personalized treatment of head and neck cancer

Official title: Novel OrganoPET Assay for Precision Therapy of Head and Neck Cancer

Funded at Stanford University · NIH-10880693 · Data updated 2026-11-12

This study is working on better treatments for head and neck cancer by creating mini versions of tumors from patients, so doctors can see how different treatments might work best for each person's unique cancer.

More Head and Neck Cancer research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startJuly 3, 2023
Project endJune 30, 2025
Funding year2024
Award (this year)$162,324
NIH project number5K99DE032094-02
Project IDNIH-10880693 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with head and neck squamous cell carcinoma who are facing challenges with current treatment options.

Less likely to help

Patients with other types of cancers or those who do not have head and neck squamous cell carcinoma may not benefit from this research.

What this research studies

This research focuses on improving treatment for head and neck squamous cell carcinomas (HNSCCs), which are known for their complexity and resistance to therapies. The project aims to develop a high-throughput platform to create patient-derived tumor organoids, allowing researchers to study how different genetic and epigenetic profiles affect responses to drugs and radiation. By correlating treatment responses with DNA methylation patterns, the research seeks to enhance precision in clinical decision-making for HNSCC patients. This innovative approach could lead to more effective, personalized therapies based on individual tumor characteristics.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with head and neck cancer.

How similar studies have gone: Previous research has shown promise in using similar approaches to classify cancer subtypes and tailor treatments, indicating potential for success in this novel application.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Khan, Syamantak — Stanford University
  • Study coordinator: Khan, Syamantak

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.